Gerald E Beckham, MD
Cardiovascular Disease (Cardiology) · Whittier
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 22 years
- Albany Medical College of Union University, 2004
Offices
5 locations · Pih Health Physicians · 616 clinicians in this group
Looking this up.
Hospitals listed: Pih Health Downey Hospital · Pih Health Hospital-Whittier. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Beckham’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A95410 · Current
Licensed to practise in California · since 2006 · expires 2027-10-31 · Albany Medical College of Union University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pih Health Downey HospitalDowney, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of PIH Health, which runs 3 hospitalsPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
See every measure and the patient survey for Pih Health Downey Hospital
Behind the star rating — Deaths: 1 better, 5 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.21 to 2.34) · 403 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.44 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 178 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.9 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.1 · 160 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,052 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,633 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,714 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (0.61 to 5.59) · 276 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.89 (0 to 18.8) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.46) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.22) · 2,012 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.198 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 124 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.1 · 614 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.7 · 229 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.5 · 234 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.3 to 16.8) · 432 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 156 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,108 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$148,863
Medicare paid this office $148,863 for 664 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 394 | $57,405 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $20,481 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 148 | $17,828 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 236 | $14,254 | $56 |
| New patient visit (45+ min) | 75 | $9,475 | $126 |
See all 17 services
| Return visit (30+ min) | 394 | $57,405 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $20,481 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 148 | $17,828 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 236 | $14,254 | $56 |
| New patient visit (45+ min) | 75 | $9,475 | $126 |
| Short return visit (20+ min) | 71 | $5,102 | $65 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,091 | $204 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 15 | $2,126 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 110 | $1,272 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 71 | $1,237 | $17 |
| New patient visit (30+ min) | 14 | $887 | $63 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $883 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 69 | $792 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $627 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $388 | $16 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $175 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $48 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
664 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 20% · Women 55% · Also on Medicaid 26% · Health risk score 2.07. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 44% · Chronic kidney disease 37% · Atrial fibrillation 36% · Heart failure 32% · Depression 19% · Cancer 18% · COPD 17% · Stroke 15% · Dementia 9%.
The office billed $618,020, Medicare allowed $201,971 and paid $148,863; for 2,094 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 664 | 2,094 | 75 | 2.07 | $618,020 | $148,863 |
| 2023 | 650 | 2,219 | 75 | 1.95 | $672,549 | $166,589 |
| 2022 | 611 | 2,143 | 76 | 1.93 | $483,770 | $150,861 |
| 2021 | 635 | 2,206 | 76 | 2.14 | $508,280 | $159,948 |
| 2020 | 560 | 1,976 | 75 | 2.58 | $449,367 | $144,804 |
| 2019 | 638 | 2,224 | 76 | 2.32 | $498,392 | $157,064 |
| 2018 | 635 | 2,207 | 75 | 2.48 | $510,370 | $154,568 |
| 2017 | 610 | 2,327 | 76 | 2.38 | $498,374 | $168,147 |
| 2016 | 576 | 2,124 | 77 | 2.23 | $423,488 | $152,778 |
| 2015 | 507 | 1,908 | 76 | 2.54 | $391,579 | $143,710 |
| 2014 | 489 | 1,906 | 77 | 2.23 | $383,275 | $135,097 |
| 2013 | 476 | 1,719 | 76 | 2.25 | $330,220 | $115,522 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Return visit (30+ min) | 358 | $60,414 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 129 | $21,682 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 146 | $16,721 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 231 | $14,256 | $58 |
| New patient visit (45+ min) | 67 | $8,881 | $133 |
| Short return visit (20+ min) | 107 | $7,966 | $65 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,477 | $432 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,021 | $188 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $2,296 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $2,084 | $91 |
| New patient visit (30+ min) | 19 | $1,545 | $81 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 80 | $1,436 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 104 | $1,268 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 23 | $1,038 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 79 | $933 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 20 | $421 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $210 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $205 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $53 | $3 |
2022: 19 services
| Return visit (30+ min) | 273 | $44,981 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $21,363 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 137 | $17,397 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 242 | $15,665 | $60 |
| Short return visit (20+ min) | 174 | $15,039 | $67 |
| New patient visit (45+ min) | 43 | $5,757 | $134 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $5,118 | $213 |
| New patient visit (30+ min) | 33 | $2,640 | $80 |
| Return visit (30+ min) | 23 | $2,291 | $85 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 91 | $1,701 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 91 | $1,138 | $12 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $1,133 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 91 | $1,043 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $858 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 16 | $326 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 16 | $298 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $202 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $177 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $43 | $3 |
2021: 18 services
| Return visit (30+ min) | 255 | $41,811 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $19,294 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 115 | $19,220 | $62 |
| Short return visit (20+ min) | 205 | $18,727 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 124 | $15,849 | $112 |
| New patient visit (45+ min) | 55 | $7,790 | $142 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $7,048 | $214 |
| New patient visit (30+ min) | 45 | $4,080 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 95 | $1,675 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 31 | $1,641 | $26 |
| Return visit (30+ min) | 15 | $1,560 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 116 | $1,473 | $12 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,318 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 95 | $1,135 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $382 | $17 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 11 | $180 | $16 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $173 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $38 | $3 |
2020: 20 services
| Return visit (30+ min) | 234 | $30,621 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $20,752 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 219 | $14,854 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 109 | $14,757 | $120 |
| Telephone medical discussion with physician, 11-20 minutes | 158 | $12,846 | $62 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $8,218 | $433 |
| New patient visit (45+ min) | 58 | $7,412 | $128 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $6,818 | $207 |
| Short return visit (20+ min) | 95 | $6,034 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,348 | $176 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 87 | $1,728 | $20 |
| New patient visit (30+ min) | 20 | $1,472 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 90 | $1,379 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 86 | $1,143 | $13 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,072 | $97 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $985 | $76 |
| Return visit (30+ min) | 12 | $832 | $69 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 17 | $421 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $245 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $51 | $3 |
2019: 19 services
| Return visit (30+ min) | 244 | $33,609 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 148 | $25,790 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 150 | $20,910 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 286 | $19,772 | $64 |
| Short return visit (20+ min) | 199 | $13,424 | $53 |
| New patient visit (45+ min) | 55 | $7,567 | $138 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,547 | $205 |
| New patient visit (30+ min) | 44 | $3,971 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 101 | $1,941 | $19 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,921 | $175 |
| New patient visit (45+ min) | 17 | $1,891 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 119 | $1,793 | $15 |
| Return visit (30+ min) | 25 | $1,772 | $68 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,527 | $95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 101 | $1,300 | $13 |
| Follow-up observation care per day, typically 25 minutes | 15 | $947 | $63 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $273 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $255 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $67 | $3 |
2018: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 166 | $27,852 | $62 |
| Return visit (30+ min) | 203 | $26,981 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 148 | $19,550 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $19,079 | $62 |
| Short return visit (20+ min) | 237 | $18,141 | $55 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,535 | $443 |
| New patient visit (45+ min) | 42 | $5,656 | $135 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,479 | $196 |
| New patient visit (30+ min) | 32 | $2,971 | $93 |
| New patient visit (45+ min) | 20 | $2,188 | $109 |
| Return visit (30+ min) | 30 | $2,139 | $67 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 95 | $1,792 | $19 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,754 | $159 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 81 | $1,232 | $15 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,217 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 95 | $1,207 | $13 |
| Follow-up observation care per day, typically 25 minutes | 13 | $811 | $62 |
| Programming of dual lead implantable defibrillator system | 12 | $497 | $31 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $237 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $205 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $38 | $3 |
2017: 19 services
| Return visit (30+ min) | 253 | $38,691 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 181 | $32,535 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 174 | $24,730 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 238 | $13,817 | $54 |
| Short return visit (20+ min) | 148 | $11,436 | $57 |
| New patient visit (45+ min) | 56 | $7,079 | $126 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,704 | $447 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 28 | $5,846 | $202 |
| New patient visit (45+ min) | 44 | $4,688 | $107 |
| Return visit (30+ min) | 38 | $2,941 | $67 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,496 | $93 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 79 | $1,480 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 91 | $1,300 | $14 |
| Follow-up observation care per day, typically 25 minutes | 19 | $1,241 | $62 |
| New patient visit (30+ min) | 14 | $1,047 | $75 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 79 | $989 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $730 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $330 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $57 | $2 |
2016: 18 services
| Return visit (30+ min) | 223 | $36,479 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 174 | $28,911 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 140 | $17,990 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 208 | $11,652 | $54 |
| New patient visit (45+ min) | 80 | $10,375 | $130 |
| Short return visit (20+ min) | 127 | $10,047 | $56 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | $8,599 | $226 |
| New patient visit (45+ min) | 37 | $3,972 | $107 |
| Return visit (30+ min) | 28 | $2,261 | $67 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,652 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 97 | $1,453 | $14 |
| Follow-up observation care per day, typically 25 minutes | 20 | $1,358 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 63 | $1,194 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 63 | $777 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 12 | $549 | $29 |
| Short return visit (20+ min) | 11 | $477 | $43 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $329 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $60 | $3 |
2015: 17 services
| Return visit (30+ min) | 215 | $36,153 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 175 | $27,980 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 182 | $23,497 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | $9,807 | $52 |
| New patient visit (45+ min) | 65 | $8,833 | $136 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,686 | $514 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $5,155 | $215 |
| Short return visit (20+ min) | 66 | $4,711 | $59 |
| New patient visit (45+ min) | 20 | $1,995 | $100 |
| Return visit (30+ min) | 24 | $1,715 | $66 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,328 | $102 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 68 | $1,022 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 53 | $967 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $717 | $28 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 52 | $623 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 28 | $435 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $85 | $3 |
2014: 17 services
| Return visit (30+ min) | 182 | $29,771 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 168 | $25,178 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 168 | $22,061 | $114 |
| New patient visit (45+ min) | 72 | $9,279 | $129 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 151 | $8,584 | $53 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $6,715 | $224 |
| Short return visit (20+ min) | 60 | $4,486 | $55 |
| Return visit (30+ min) | 33 | $3,164 | $66 |
| New patient visit (45+ min) | 22 | $2,407 | $109 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,679 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 79 | $1,450 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 75 | $1,114 | $14 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 19 | $1,087 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 78 | $947 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 35 | $560 | $15 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 14 | $405 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 36 | $108 | $3 |
2013: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 156 | $23,772 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 158 | $18,997 | $110 |
| Return visit (30+ min) | 114 | $16,553 | $87 |
| Short return visit (20+ min) | 121 | $9,337 | $53 |
| New patient visit (45+ min) | 69 | $9,148 | $133 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $7,239 | $226 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 123 | $6,925 | $52 |
| New patient visit (45+ min) | 41 | $4,236 | $103 |
| Return visit (30+ min) | 30 | $2,223 | $64 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,526 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 82 | $1,350 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,085 | $52 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 16 | $869 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 43 | $753 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 33 | $496 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | $488 | $12 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 13 | $349 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $106 | $3 |
Medicaid work
$3,297 in 2024
Medicaid paid $3,297 for 68 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 43 | $1,814 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 25 | $1,483 |
| 2024 | 68 | 2 | 18 | $3,297 |
| 2018 | 22 | 1 | 12 | $480 |
See the largest Medicaid services in earlier years
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 22 | $480 |
Drugs they prescribed that Part D paid
$1,675,622
Pharmacies billed $1,675,622 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
5,623 generic and 1,558 brand-name prescriptions · $1,675,622 in drug cost · 11 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 1,012 | $1,189,400 | $1,175 |
| Xarelto | 155 | $156,299 | $1,008 |
| Entresto | 69 | $86,329 | $1,251 |
| Brilinta | 61 | $63,742 | $1,045 |
| Multaq | 19 | $33,829 | $1,780 |
See all 55 drugs
| Eliquis | 1,012 | $1,189,400 | $1,175 |
| Xarelto | 155 | $156,299 | $1,008 |
| Entresto | 69 | $86,329 | $1,251 |
| Brilinta | 61 | $63,742 | $1,045 |
| Multaq | 19 | $33,829 | $1,780 |
| Repatha Sureclick | 33 | $19,928 | $604 |
| Dabigatran Etexilate | 29 | $10,230 | $353 |
| Ranolazine Er | 58 | $6,447 | $111 |
| Clopidogrel | 404 | $5,835 | $14 |
| Isosorbide Mononitrate Er | 280 | $5,223 | $19 |
| Metoprolol | 297 | $4,889 | $16 |
| Metoprolol | 641 | $4,835 | $8 |
| Losartan | 332 | $4,459 | $13 |
| Furosemide | 505 | $3,778 | $7 |
| Atorvastatin | 309 | $3,698 | $12 |
| Diltiazem 24hr Er (Cd) | 62 | $3,663 | $59 |
| Amiodarone | 139 | $3,491 | $25 |
| Carvedilol | 312 | $3,173 | $10 |
| Diltiazem 12hr Er | 15 | $3,088 | $206 |
| Potassium Chloride | 118 | $2,915 | $25 |
| Digoxin | 131 | $2,762 | $21 |
| Clonidine | 19 | $2,633 | $139 |
| Midodrine | 28 | $2,398 | $86 |
| Nitroglycerin | 232 | $2,221 | $10 |
| Lisinopril | 262 | $2,091 | $8 |
| Amlodipine Besylate | 357 | $1,983 | $6 |
| Hydralazine | 100 | $1,804 | $18 |
| Bumetanide | 26 | $1,797 | $69 |
| Valsartan | 35 | $1,475 | $42 |
| Diltiazem 24hr Er (Xr) | 26 | $1,336 | $51 |
| Diltiazem | 27 | $1,267 | $47 |
| Atenolol | 137 | $1,080 | $8 |
| Metolazone | 42 | $1,066 | $25 |
| Sotalol | 43 | $968 | $23 |
| Losartan-Hydrochlorothiazide | 45 | $945 | $21 |
| Labetalol | 17 | $925 | $54 |
| Propafenone | 21 | $902 | $43 |
| Flecainide Acetate | 35 | $891 | $25 |
| Ezetimibe | 22 | $870 | $40 |
| Dilt-Xr | 14 | $860 | $61 |
| Diltiazem 24hr Er | 17 | $787 | $46 |
| Benazepril | 52 | $594 | $11 |
| Rosuvastatin | 51 | $549 | $11 |
| Irbesartan | 26 | $436 | $17 |
| Chlorthalidone | 18 | $396 | $22 |
| Simvastatin | 40 | $391 | $10 |
| Hydrochlorothiazide | 127 | $390 | $3 |
| Enalapril Maleate | 15 | $368 | $25 |
| Nifedipine Er | 23 | $359 | $16 |
| Spironolactone | 28 | $337 | $12 |
| Valsartan-Hydrochlorothiazide | 12 | $309 | $26 |
| Clonidine | 25 | $236 | $9 |
| Klor-Con 10 | 12 | $235 | $20 |
| Bisoprolol | 11 | $216 | $20 |
| Triamterene-Hydrochlorothiazid | 11 | $104 | $9 |
Year by year
| 2024 | 7,181 | 1,167 | None | 22% | $1,675,622 |
| 2023 | 6,861 | 1,112 | 0% (0) | 21% | $1,514,348 |
| 2022 | 6,259 | 1,070 | None | 19% | $1,274,000 |
| 2021 | 5,605 | 986 | 0% (0) | 20% | $989,935 |
| 2020 | 5,144 | 936 | 0% (0) | 21% | $790,969 |
| 2019 | 5,118 | 925 | None | None | $636,499 |
| 2018 | 4,672 | 901 | 0% (0) | 18% | $450,146 |
| 2017 | 4,347 | 872 | None | 20% | $298,515 |
| 2016 | 3,803 | 726 | None | 19% | $222,105 |
| 2015 | 3,186 | 560 | None | None | $160,212 |
| 2014 | 2,936 | 469 | 0% (0) | 17% | $134,312 |
| 2013 | 2,496 | 412 | 0% (0) | 18% | $97,657 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Eliquis | 883 | $978,020 | $1,108 |
| Xarelto | 151 | $161,821 | $1,072 |
| Brilinta | 71 | $73,508 | $1,035 |
| Entresto | 44 | $52,510 | $1,193 |
| Multaq | 21 | $36,264 | $1,727 |
| Repatha Sureclick | 37 | $25,914 | $700 |
| Ranolazine Er | 54 | $9,132 | $169 |
| Isosorbide Mononitrate Er | 253 | $8,815 | $35 |
| Clopidogrel | 392 | $7,998 | $20 |
| Metoprolol | 304 | $7,911 | $26 |
| Midodrine | 42 | $6,805 | $162 |
| Losartan | 290 | $6,795 | $23 |
| Metoprolol | 609 | $6,127 | $10 |
| Atorvastatin | 292 | $5,894 | $20 |
| Digoxin | 143 | $5,617 | $39 |
| Carvedilol | 339 | $5,565 | $16 |
| Potassium Chloride | 119 | $5,486 | $46 |
| Diltiazem 24hr Er (Cd) | 64 | $5,411 | $85 |
| Furosemide | 501 | $5,183 | $10 |
| Amiodarone | 123 | $4,857 | $39 |
| Amlodipine Besylate | 359 | $4,310 | $12 |
| Nitroglycerin | 227 | $3,861 | $17 |
| Hydralazine | 110 | $3,542 | $32 |
| Metolazone | 45 | $3,501 | $78 |
| Lisinopril | 244 | $3,472 | $14 |
| Labetalol | 26 | $2,527 | $97 |
| Atenolol | 170 | $2,467 | $15 |
| Diltiazem 24hr Er (Xr) | 28 | $2,001 | $71 |
| Pacerone | 11 | $1,965 | $179 |
| Valsartan | 30 | $1,962 | $65 |
| Clonidine | 13 | $1,858 | $143 |
| Irbesartan | 24 | $1,773 | $74 |
| Propafenone | 21 | $1,630 | $78 |
| Losartan-Hydrochlorothiazide | 44 | $1,553 | $35 |
| Benazepril | 56 | $1,151 | $21 |
| Sotalol | 37 | $1,084 | $29 |
| Valsartan-Hydrochlorothiazide | 15 | $1,081 | $72 |
| Flecainide Acetate | 24 | $1,080 | $45 |
| Nifedipine Er | 16 | $1,075 | $67 |
| Felodipine Er | 13 | $1,064 | $82 |
| Ezetimibe | 22 | $999 | $45 |
| Clonidine | 32 | $892 | $28 |
| Klor-Con 10 | 20 | $651 | $33 |
| Diltiazem | 16 | $633 | $40 |
| Hydrochlorothiazide | 125 | $601 | $5 |
| Diltiazem 24hr Er | 11 | $591 | $54 |
| Simvastatin | 35 | $581 | $17 |
| Spironolactone-Hctz | 11 | $544 | $49 |
| Enalapril Maleate | 17 | $534 | $31 |
| Rosuvastatin | 38 | $484 | $13 |
| Amlodipine Besylate-Benazepril | 14 | $423 | $30 |
| Chlorthalidone | 12 | $381 | $32 |
| Spironolactone | 35 | $340 | $10 |
2022: 51 drugs
| Eliquis | 668 | $756,334 | $1,132 |
| Xarelto | 169 | $174,828 | $1,034 |
| Brilinta | 66 | $68,866 | $1,043 |
| Entresto | 60 | $60,832 | $1,014 |
| Multaq | 15 | $25,511 | $1,701 |
| Pradaxa | 11 | $15,137 | $1,376 |
| Repatha Sureclick | 18 | $14,061 | $781 |
| Isosorbide Mononitrate Er | 258 | $7,761 | $30 |
| Ranolazine Er | 47 | $7,746 | $165 |
| Midodrine | 23 | $7,166 | $312 |
| Metoprolol | 246 | $6,636 | $27 |
| Clopidogrel | 333 | $6,553 | $20 |
| Potassium Chloride | 109 | $6,052 | $56 |
| Metoprolol | 556 | $5,781 | $10 |
| Digoxin | 124 | $5,443 | $44 |
| Losartan | 278 | $5,290 | $19 |
| Nitroglycerin | 246 | $5,125 | $21 |
| Diltiazem 24hr Er (Cd) | 76 | $5,116 | $67 |
| Furosemide | 519 | $4,934 | $10 |
| Amiodarone | 138 | $4,629 | $34 |
| Carvedilol | 290 | $4,340 | $15 |
| Atorvastatin | 226 | $3,976 | $18 |
| Hydralazine | 140 | $3,950 | $28 |
| Amlodipine Besylate | 370 | $3,491 | $9 |
| Lisinopril | 244 | $2,397 | $10 |
| Nifedipine Er | 20 | $2,259 | $113 |
| Metolazone | 24 | $1,892 | $79 |
| Propafenone | 24 | $1,815 | $76 |
| Ezetimibe | 29 | $1,729 | $60 |
| Atenolol | 141 | $1,659 | $12 |
| Flecainide Acetate | 24 | $1,533 | $64 |
| Irbesartan | 15 | $1,511 | $101 |
| Labetalol | 26 | $1,471 | $57 |
| Valsartan | 24 | $1,425 | $59 |
| Diltiazem 24hr Er (Xr) | 18 | $1,333 | $74 |
| Rosuvastatin | 39 | $1,012 | $26 |
| Felodipine Er | 17 | $988 | $58 |
| Sotalol | 33 | $972 | $29 |
| Losartan-Hydrochlorothiazide | 31 | $929 | $30 |
| Benazepril | 52 | $876 | $17 |
| Diltiazem | 17 | $740 | $44 |
| Hydrochlorothiazide | 101 | $696 | $7 |
| Enalapril Maleate | 28 | $651 | $23 |
| Klor-Con 10 | 18 | $604 | $34 |
| Spironolactone | 33 | $504 | $15 |
| Simvastatin | 36 | $392 | $11 |
| Amlodipine Besylate-Benazepril | 11 | $335 | $30 |
| Gabapentin | 11 | $334 | $30 |
| Clonidine | 23 | $308 | $13 |
| Ramipril | 11 | $171 | $16 |
| Pravastatin | 13 | $158 | $12 |
2021: 49 drugs
| Eliquis | 586 | $572,470 | $977 |
| Xarelto | 137 | $133,397 | $974 |
| Entresto | 69 | $62,452 | $905 |
| Brilinta | 68 | $60,501 | $890 |
| Multaq | 11 | $19,600 | $1,782 |
| Pradaxa | 13 | $16,107 | $1,239 |
| Isosorbide Mononitrate Er | 233 | $6,584 | $28 |
| Repatha Sureclick | 12 | $5,957 | $496 |
| Diltiazem 24hr Er (Cd) | 55 | $5,160 | $94 |
| Potassium Chloride | 104 | $4,888 | $47 |
| Metoprolol | 195 | $4,831 | $25 |
| Metoprolol | 467 | $4,772 | $10 |
| Losartan | 220 | $4,635 | $21 |
| Clopidogrel | 312 | $4,474 | $14 |
| Furosemide | 510 | $4,216 | $8 |
| Digoxin | 94 | $4,180 | $44 |
| Amiodarone | 102 | $4,153 | $41 |
| Nitroglycerin | 184 | $3,416 | $19 |
| Diltiazem 12hr Er | 13 | $3,357 | $258 |
| Atorvastatin | 191 | $3,329 | $17 |
| Ranolazine Er | 37 | $3,328 | $90 |
| Carvedilol | 269 | $3,265 | $12 |
| Metolazone | 33 | $3,260 | $99 |
| Hydralazine | 127 | $3,001 | $24 |
| Amlodipine Besylate | 318 | $2,507 | $8 |
| Ezetimibe | 31 | $2,285 | $74 |
| Lisinopril | 287 | $2,239 | $8 |
| Dilt-Xr | 28 | $1,667 | $60 |
| Flecainide Acetate | 29 | $1,660 | $57 |
| Midodrine | 17 | $1,594 | $94 |
| Atenolol | 137 | $1,481 | $11 |
| Nifedipine Er | 16 | $1,432 | $89 |
| Irbesartan | 13 | $1,361 | $105 |
| Losartan-Hydrochlorothiazide | 29 | $1,261 | $43 |
| Felodipine Er | 21 | $1,200 | $57 |
| Benazepril | 75 | $1,118 | $15 |
| Propafenone | 18 | $924 | $51 |
| Sotalol | 32 | $818 | $26 |
| Labetalol | 18 | $795 | $44 |
| Rosuvastatin | 24 | $710 | $30 |
| Hydrochlorothiazide | 99 | $673 | $7 |
| Enalapril Maleate | 29 | $655 | $23 |
| Bisoprolol | 12 | $626 | $52 |
| Diltiazem | 15 | $582 | $39 |
| Clonidine | 25 | $488 | $20 |
| Spironolactone | 29 | $421 | $15 |
| Simvastatin | 45 | $408 | $9 |
| Ramipril | 12 | $215 | $18 |
| Pravastatin | 11 | $197 | $18 |
2020: 53 drugs
| Eliquis | 381 | $370,102 | $971 |
| Xarelto | 173 | $148,554 | $859 |
| Entresto | 72 | $60,918 | $846 |
| Brilinta | 44 | $31,268 | $711 |
| Pradaxa | 30 | $25,019 | $834 |
| Multaq | 17 | $22,383 | $1,317 |
| Repatha Sureclick | 24 | $11,340 | $473 |
| Isosorbide Mononitrate Er | 227 | $7,653 | $34 |
| Metoprolol | 189 | $6,234 | $33 |
| Amiodarone | 125 | $5,581 | $45 |
| Potassium Chloride | 85 | $5,105 | $60 |
| Clopidogrel | 306 | $5,054 | $17 |
| Digoxin | 95 | $4,548 | $48 |
| Nitroglycerin | 189 | $3,678 | $19 |
| Metoprolol | 396 | $3,555 | $9 |
| Furosemide | 438 | $3,526 | $8 |
| Ranolazine Er | 23 | $3,317 | $144 |
| Carvedilol | 270 | $3,272 | $12 |
| Atorvastatin | 155 | $3,233 | $21 |
| Hydralazine | 124 | $3,177 | $26 |
| Diltiazem 24hr Er (Cd) | 37 | $3,095 | $84 |
| Amlodipine Besylate | 314 | $2,913 | $9 |
| Dilt-Xr | 37 | $2,895 | $78 |
| Losartan | 159 | $2,646 | $17 |
| Flecainide Acetate | 28 | $2,433 | $87 |
| Ezetimibe | 30 | $2,380 | $79 |
| Nifedipine Er | 24 | $2,136 | $89 |
| Metolazone | 32 | $2,004 | $63 |
| Lisinopril | 244 | $1,928 | $8 |
| Rosuvastatin | 23 | $1,707 | $74 |
| Midodrine | 14 | $1,683 | $120 |
| Atenolol | 140 | $1,651 | $12 |
| Felodipine Er | 18 | $1,647 | $92 |
| Valsartan | 19 | $1,247 | $66 |
| Clonidine | 40 | $1,217 | $30 |
| Isosorbide Dinitrate | 14 | $1,136 | $81 |
| Propafenone | 13 | $1,098 | $84 |
| Clonidine | 11 | $938 | $85 |
| Irbesartan | 13 | $929 | $71 |
| Sotalol | 33 | $927 | $28 |
| Niacin Er | 12 | $911 | $76 |
| Losartan-Hydrochlorothiazide | 14 | $756 | $54 |
| Bisoprolol | 13 | $756 | $58 |
| Benazepril | 55 | $755 | $14 |
| Cartia Xt | 19 | $702 | $37 |
| Hydrochlorothiazide | 83 | $671 | $8 |
| Enalapril Maleate | 19 | $645 | $34 |
| Diltiazem 24hr Er | 11 | $535 | $49 |
| Spironolactone | 31 | $472 | $15 |
| Diltiazem | 13 | $425 | $33 |
| Ramipril | 22 | $350 | $16 |
| Simvastatin | 46 | $320 | $7 |
| Pravastatin | 14 | $128 | $9 |
2019: 51 drugs
| Eliquis | 265 | $213,634 | $806 |
| Xarelto | 155 | $136,802 | $883 |
| Pradaxa | 51 | $39,682 | $778 |
| Multaq | 31 | $39,624 | $1,278 |
| Entresto | 69 | $37,809 | $548 |
| Brilinta | 25 | $20,099 | $804 |
| Metoprolol | 205 | $10,194 | $50 |
| Isosorbide Mononitrate Er | 287 | $10,005 | $35 |
| Praluent | 12 | $9,891 | $824 |
| Clopidogrel | 295 | $7,045 | $24 |
| Amiodarone | 105 | $6,798 | $65 |
| Hydralazine | 126 | $5,535 | $44 |
| Diovan | 11 | $5,099 | $464 |
| Potassium Chloride | 103 | $4,527 | $44 |
| Nitroglycerin | 220 | $4,400 | $20 |
| Carvedilol | 268 | $4,331 | $16 |
| Furosemide | 444 | $4,331 | $10 |
| Amlodipine Besylate | 310 | $4,199 | $14 |
| Metoprolol | 438 | $4,062 | $9 |
| Ranolazine Er | 11 | $4,044 | $368 |
| Digoxin | 74 | $3,803 | $51 |
| Lisinopril | 280 | $3,112 | $11 |
| Nifedipine Er | 36 | $3,110 | $86 |
| Rosuvastatin | 22 | $3,062 | $139 |
| Atorvastatin | 123 | $2,969 | $24 |
| Atenolol | 168 | $2,515 | $15 |
| Flecainide Acetate | 25 | $2,340 | $94 |
| Losartan | 138 | $1,866 | $14 |
| Cartia Xt | 24 | $1,699 | $71 |
| Metolazone | 31 | $1,561 | $50 |
| Isosorbide Dinitrate | 14 | $1,560 | $111 |
| Dilt-Xr | 25 | $1,545 | $62 |
| Clonidine | 14 | $1,542 | $110 |
| Digitek | 24 | $1,406 | $59 |
| Diltiazem 24hr Er (Cd) | 28 | $1,350 | $48 |
| Midodrine | 14 | $1,344 | $96 |
| Ezetimibe | 19 | $1,324 | $70 |
| Sotalol | 27 | $1,219 | $45 |
| Labetalol | 14 | $1,168 | $83 |
| Clonidine | 33 | $1,145 | $35 |
| Diltiazem | 26 | $1,051 | $40 |
| Digox | 15 | $1,016 | $68 |
| Benazepril | 47 | $824 | $18 |
| Propafenone | 11 | $750 | $68 |
| Hydrochlorothiazide | 97 | $746 | $8 |
| Simvastatin | 45 | $524 | $12 |
| Spironolactone | 40 | $492 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $483 | $35 |
| Ramipril | 24 | $454 | $19 |
| Enalapril Maleate | 18 | $354 | $20 |
| Meclizine | 11 | $62 | $6 |
2018: 45 drugs
| Xarelto | 161 | $109,504 | $680 |
| Eliquis | 153 | $105,061 | $687 |
| Multaq | 29 | $36,624 | $1,263 |
| Pradaxa | 36 | $27,889 | $775 |
| Entresto | 46 | $21,985 | $478 |
| Brilinta | 21 | $13,001 | $619 |
| Isosorbide Mononitrate Er | 259 | $10,137 | $39 |
| Metoprolol | 174 | $10,078 | $58 |
| Clopidogrel | 257 | $6,286 | $24 |
| Amiodarone | 109 | $5,870 | $54 |
| Potassium Chloride | 111 | $5,786 | $52 |
| Diovan | 28 | $5,711 | $204 |
| Hydralazine | 109 | $5,457 | $50 |
| Carvedilol | 277 | $5,333 | $19 |
| Digoxin | 79 | $4,355 | $55 |
| Amlodipine Besylate | 242 | $4,062 | $17 |
| Furosemide | 463 | $4,028 | $9 |
| Nitroglycerin | 173 | $3,656 | $21 |
| Lisinopril | 289 | $3,448 | $12 |
| Metoprolol | 391 | $3,280 | $8 |
| Atenolol | 193 | $2,813 | $15 |
| Midodrine | 27 | $2,423 | $90 |
| Losartan | 150 | $2,390 | $16 |
| Digox | 29 | $2,221 | $77 |
| Rosuvastatin | 16 | $2,120 | $133 |
| Nifedipine Er | 20 | $2,076 | $104 |
| Enoxaparin | 12 | $1,987 | $166 |
| Diltiazem 12hr Er | 14 | $1,805 | $129 |
| Diltiazem | 31 | $1,745 | $56 |
| Diltiazem 24hr Er (Cd) | 45 | $1,732 | $38 |
| Atorvastatin | 67 | $1,714 | $26 |
| Cartia Xt | 18 | $1,530 | $85 |
| Metolazone | 30 | $1,513 | $50 |
| Digitek | 23 | $1,426 | $62 |
| Labetalol | 21 | $1,350 | $64 |
| Sotalol | 28 | $1,245 | $44 |
| Dilt-Xr | 16 | $1,135 | $71 |
| Flecainide Acetate | 23 | $1,045 | $45 |
| Clonidine | 37 | $1,013 | $27 |
| Benazepril | 46 | $835 | $18 |
| Hydrochlorothiazide | 97 | $799 | $8 |
| Valsartan | 15 | $727 | $48 |
| Simvastatin | 54 | $616 | $11 |
| Lovastatin | 13 | $264 | $20 |
| Spironolactone | 17 | $181 | $11 |
2017: 42 drugs
| Xarelto | 121 | $80,844 | $668 |
| Multaq | 37 | $41,509 | $1,122 |
| Pradaxa | 52 | $41,423 | $797 |
| Eliquis | 59 | $33,435 | $567 |
| Brilinta | 15 | $12,038 | $803 |
| Ranexa | 17 | $11,990 | $705 |
| Isosorbide Mononitrate Er | 241 | $6,173 | $26 |
| Metoprolol | 133 | $4,548 | $34 |
| Digoxin | 69 | $4,034 | $58 |
| Nitroglycerin | 192 | $4,015 | $21 |
| Clopidogrel | 274 | $3,830 | $14 |
| Potassium Chloride | 94 | $3,590 | $38 |
| Metoprolol | 390 | $3,586 | $9 |
| Furosemide | 424 | $2,820 | $7 |
| Carvedilol | 284 | $2,565 | $9 |
| Diltiazem 24hr Er | 61 | $2,418 | $40 |
| Digox | 36 | $2,278 | $63 |
| Hydralazine | 94 | $2,273 | $24 |
| Amiodarone | 97 | $2,161 | $22 |
| Diltiazem 12hr Er | 12 | $1,950 | $162 |
| Diltiazem | 35 | $1,759 | $50 |
| Amlodipine Besylate | 223 | $1,506 | $7 |
| Atenolol | 209 | $1,454 | $7 |
| Lisinopril | 271 | $1,406 | $5 |
| Digitek | 19 | $1,343 | $71 |
| Sotalol | 28 | $1,301 | $46 |
| Midodrine | 18 | $1,256 | $70 |
| Atorvastatin | 73 | $1,201 | $16 |
| Losartan | 140 | $1,099 | $8 |
| Metolazone | 23 | $961 | $42 |
| Nifedipine Er | 12 | $823 | $69 |
| Hydrochlorothiazide | 107 | $655 | $6 |
| Enalapril Maleate | 13 | $606 | $47 |
| Benazepril | 59 | $551 | $9 |
| Valsartan | 16 | $503 | $31 |
| Cartia Xt | 11 | $486 | $44 |
| Clonidine | 25 | $392 | $16 |
| Simvastatin | 64 | $389 | $6 |
| Irbesartan | 15 | $326 | $22 |
| Spironolactone | 21 | $138 | $7 |
| Warfarin | 22 | $108 | $5 |
| Cephalexin | 12 | $35 | $3 |
2016: 46 drugs
| Multaq | 56 | $41,782 | $746 |
| Xarelto | 51 | $31,237 | $612 |
| Pradaxa | 46 | $27,596 | $600 |
| Brilinta | 35 | $15,368 | $439 |
| Eliquis | 20 | $10,885 | $544 |
| Ranexa | 14 | $8,582 | $613 |
| Isosorbide Mononitrate Er | 289 | $8,027 | $28 |
| Digox | 53 | $4,918 | $93 |
| Amiodarone | 72 | $4,506 | $63 |
| Potassium Chloride | 97 | $4,447 | $46 |
| Metoprolol | 371 | $4,346 | $12 |
| Digoxin | 50 | $3,800 | $76 |
| Clopidogrel | 220 | $3,778 | $17 |
| Carvedilol | 287 | $3,772 | $13 |
| Metoprolol | 114 | $3,771 | $33 |
| Enoxaparin | 21 | $3,214 | $153 |
| Furosemide | 333 | $3,123 | $9 |
| Hydralazine | 67 | $2,980 | $44 |
| Nitrostat | 104 | $2,905 | $28 |
| Lisinopril | 229 | $2,059 | $9 |
| Atorvastatin | 85 | $1,775 | $21 |
| Losartan | 126 | $1,595 | $13 |
| Metolazone | 14 | $1,368 | $98 |
| Amlodipine Besylate | 182 | $1,290 | $7 |
| Diltiazem | 37 | $1,280 | $35 |
| Sotalol | 27 | $1,256 | $47 |
| Atenolol | 154 | $1,146 | $7 |
| Diltiazem 24hr Er | 27 | $987 | $37 |
| Digitek | 12 | $980 | $82 |
| Labetalol | 20 | $968 | $48 |
| Midodrine | 13 | $931 | $72 |
| Simvastatin | 99 | $822 | $8 |
| Nitroglycerin | 40 | $677 | $17 |
| Benazepril | 50 | $674 | $13 |
| Felodipine Er | 11 | $579 | $53 |
| Nifedipine Er | 14 | $538 | $38 |
| Irbesartan | 16 | $496 | $31 |
| Valsartan | 11 | $449 | $41 |
| Hydrochlorothiazide | 80 | $441 | $6 |
| Lansoprazole | 11 | $390 | $35 |
| Clonidine | 17 | $341 | $20 |
| Lovastatin | 17 | $292 | $17 |
| Cilostazol | 11 | $243 | $22 |
| Spironolactone | 18 | $220 | $12 |
| Warfarin | 21 | $174 | $8 |
| Losartan-Hydrochlorothiazide | 14 | $158 | $11 |
2015: 36 drugs
| Multaq | 46 | $28,881 | $628 |
| Xarelto | 46 | $25,083 | $545 |
| Eliquis | 26 | $10,119 | $389 |
| Brilinta | 17 | $8,240 | $485 |
| Pradaxa | 16 | $7,965 | $498 |
| Amiodarone | 91 | $6,887 | $76 |
| Isosorbide Mononitrate Er | 222 | $5,890 | $27 |
| Potassium Chloride | 118 | $4,549 | $39 |
| Clopidogrel | 197 | $4,425 | $22 |
| Metoprolol | 350 | $3,632 | $10 |
| Digox | 47 | $3,317 | $71 |
| Digoxin | 48 | $3,246 | $68 |
| Carvedilol | 248 | $3,224 | $13 |
| Nitrostat | 137 | $2,406 | $18 |
| Furosemide | 229 | $2,004 | $9 |
| Hydralazine | 59 | $1,971 | $33 |
| Metolazone | 19 | $1,743 | $92 |
| Atorvastatin | 84 | $1,706 | $20 |
| Lisinopril | 181 | $1,606 | $9 |
| Diltiazem | 51 | $1,306 | $26 |
| Metoprolol | 45 | $1,240 | $28 |
| Losartan | 120 | $1,195 | $10 |
| Valsartan | 12 | $1,176 | $98 |
| Atenolol | 157 | $932 | $6 |
| Felodipine Er | 14 | $857 | $61 |
| Amlodipine Besylate | 119 | $815 | $7 |
| Simvastatin | 113 | $787 | $7 |
| Diltiazem 24hr Er | 17 | $686 | $40 |
| Sotalol | 25 | $667 | $27 |
| Hydrochlorothiazide | 52 | $336 | $6 |
| Clonidine | 24 | $301 | $13 |
| Cilostazol | 16 | $277 | $17 |
| Benazepril | 20 | $245 | $12 |
| Warfarin | 17 | $188 | $11 |
| Spironolactone | 21 | $165 | $8 |
| Lovastatin | 11 | $136 | $12 |
2014: 39 drugs
| Xarelto | 33 | $16,847 | $511 |
| Multaq | 31 | $14,213 | $458 |
| Ranexa | 20 | $12,050 | $602 |
| Pradaxa | 22 | $10,204 | $464 |
| Eliquis | 21 | $6,270 | $299 |
| Isosorbide Mononitrate Er | 204 | $5,285 | $26 |
| Clopidogrel | 157 | $4,387 | $28 |
| Amiodarone | 95 | $3,915 | $41 |
| Metoprolol | 385 | $3,706 | $10 |
| Potassium Chloride | 97 | $3,617 | $37 |
| Carvedilol | 216 | $3,025 | $14 |
| Digox | 50 | $2,607 | $52 |
| Crestor | 12 | $2,280 | $190 |
| Diltiazem 24hr Er | 52 | $2,119 | $41 |
| Furosemide | 251 | $2,111 | $8 |
| Hydralazine | 44 | $1,749 | $40 |
| Metolazone | 27 | $1,748 | $65 |
| Nitrostat | 96 | $1,722 | $18 |
| Felodipine Er | 28 | $1,561 | $56 |
| Lisinopril | 184 | $1,533 | $8 |
| Digoxin | 25 | $1,305 | $52 |
| Losartan | 109 | $1,262 | $12 |
| Diltiazem Er | 20 | $1,231 | $62 |
| Atorvastatin | 52 | $1,224 | $24 |
| Metoprolol | 29 | $953 | $33 |
| Amlodipine Besylate | 90 | $907 | $10 |
| Simvastatin | 99 | $817 | $8 |
| Sotalol | 41 | $781 | $19 |
| Atenolol | 111 | $777 | $7 |
| Ramipril | 12 | $608 | $51 |
| Cilostazol | 22 | $513 | $23 |
| Diltiazem | 27 | $436 | $16 |
| Benazepril | 28 | $329 | $12 |
| Hydrochlorothiazide | 47 | $299 | $6 |
| Diltiazem 24hr Cd | 11 | $288 | $26 |
| Clonidine | 19 | $266 | $14 |
| Lisinopril-Hydrochlorothiazide | 12 | $160 | $13 |
| Spironolactone | 11 | $141 | $13 |
| Warfarin | 12 | $127 | $11 |
2013: 33 drugs
| Pradaxa | 35 | $13,454 | $384 |
| Ranexa | 21 | $9,400 | $448 |
| Clopidogrel | 145 | $6,639 | $46 |
| Multaq | 14 | $4,571 | $327 |
| Isosorbide Mononitrate Er | 179 | $4,534 | $25 |
| Crestor | 18 | $3,951 | $220 |
| Amiodarone | 63 | $3,909 | $62 |
| Metoprolol | 322 | $3,042 | $9 |
| Potassium Chloride | 72 | $2,934 | $41 |
| Carvedilol | 180 | $2,494 | $14 |
| Diltiazem Er | 29 | $2,169 | $75 |
| Diltiazem 24hr Er | 30 | $1,792 | $60 |
| Furosemide | 227 | $1,773 | $8 |
| Felodipine Er | 35 | $1,754 | $50 |
| Hydralazine | 48 | $1,619 | $34 |
| Nitrostat | 80 | $1,407 | $18 |
| Lisinopril | 160 | $1,405 | $9 |
| Atorvastatin | 46 | $1,392 | $30 |
| Amlodipine Besylate | 92 | $1,136 | $12 |
| Losartan | 58 | $1,034 | $18 |
| Simvastatin | 78 | $963 | $12 |
| Digox | 79 | $827 | $10 |
| Metolazone | 17 | $787 | $46 |
| Sotalol | 24 | $665 | $28 |
| Metoprolol | 13 | $528 | $41 |
| Atenolol | 80 | $519 | $6 |
| Cilostazol | 22 | $493 | $22 |
| Hydrochlorothiazide | 82 | $430 | $5 |
| Warfarin | 27 | $293 | $11 |
| Diltiazem | 20 | $257 | $13 |
| Benazepril | 25 | $237 | $9 |
| Clonidine | 13 | $155 | $12 |
| Digoxin | 13 | $88 | $7 |
Money from drug and device companies
$654 in 2025
| 2025 | 9 | 23 | None | $654 |
| 2024 | 7 | 18 | None | $459 |
| 2023 | 8 | 14 | None | $500 |
| 2022 | 8 | 22 | None | $633 |
| 2021 | 6 | 13 | None | $348 |
| 2020 | 7 | 14 | None | $380 |
| 2019 | 5 | 13 | None | $413 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Avvigo Guidance System | $235 | 5 payments
|
| Medtronic | Pulseselect | $155 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $114 | 7 payments
|
| Abbott Laboratories | Aveir | $32 | 1 payment
|
| Neurocrine BioSciences | Crenessity | $31 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $30 | 1 payment
|
See all 23 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-22 | Kerendia | $30 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-19 | Lifevest | $24 |
| Boston Scientific | Meals · 2025-12-16 | Avvigo Guidance System | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-12 | Lifevest | $6 |
| Boston Scientific | Meals · 2025-12-11 | Avvigo Guidance System | $26 |
| Abbott Laboratories | Meals · 2025-12-02 | Aveir | $32 |
| Scpharmaceuticals | Meals · 2025-11-07 | Furoscix | $19 |
| Neurocrine BioSciences | Meals · 2025-11-03 | Crenessity | $31 |
| Medtronic | Meals · 2025-10-28 | Pulseselect | $28 |
| Kestra Medical Technology Services | Meals · 2025-09-05 | Assure Wcd | $18 |
| Boston Scientific | Meals · 2025-08-14 | Avvigo Guidance System | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-29 | Lifevest | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-15 | Lifevest | $6 |
| Medtronic | Meals · 2025-07-02 | Affera Mapping System | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-18 | Lifevest | $19 |
| Biotronik | Meals · 2025-06-12 | Orsiro Mission | $21 |
| Medtronic | Meals · 2025-05-06 | Pulseselect | $9 |
| Medtronic | Meals · 2025-04-30 | Cobalt Dr Mri Surescan | $52 |
| Boston Scientific | Meals · 2025-03-31 | Avvigo Guidance System | $26 |
| Medtronic | Meals · 2025-03-28 | Pulseselect | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-17 | Lifevest | $19 |
| Boston Scientific | Meals · 2025-03-14 | Avvigo Guidance System | $136 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-20 | Lifevest | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $459
| Kestra Medical Technology Services | Assure Wcd | $125 | 7 payments
|
| Boston Scientific | Avvigo Guidance System | $97 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $93 | 4 payments
|
| Abiomed | Impella | $74 | 1 payment
|
| Abbott Laboratories | Aveir | $32 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $20 | 1 payment
|
| Medtronic | Micra | $19 | 1 payment
|
2023: $500
| Teleflex | Guideliner | $238 | 4 payments
|
| Abbott Laboratories | Perclose Prostyle | $90 | 4 payments
|
| Abiomed | Impella | $44 | 1 payment
|
| Biotronik | Biomonitor | $34 | 1 payment
|
| HeartFlow | Ffrct | $29 | 1 payment
|
| Boston Scientific | Avvigo Guidance System | $28 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20 | 1 payment
|
| Cardiovascular Systems | Diamondback Coronary | $18 | 1 payment
|
2022: $633
| Abiomed | Impella | $151 | 3 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $119 | 4 payments
|
| Cardiovascular Systems | Diamondback Coronary | $117 | 6 payments
|
| Abbott Laboratories | Xience Sierra | $74 | 4 payments
|
| Medtronic | Micra | $71 | 1 payment
|
| Teleflex | Chocolate | $42 | 2 payments
|
| Biotronik | Biomonitor | $33 | 1 payment
|
| Chiesi USA | Kengreal | $25 | 1 payment
|
2021: $348
| Cardiovascular Systems | Diamondback Coronary | $145 | 6 payments
|
| Shockwave Medical | Vascular Lithotripsy | $67 | 2 payments
|
| Philips Electronics North America | (9520) Igt Devices Und | $45 | 1 payment
|
| Medtronic | Linq II | $45 | 2 payments
|
| Kiniksa Pharmaceuticals | None | $25 | 1 payment
|
| Chiesi USA | Kengreal | $21 | 1 payment
|
2020: $380
| Abbott Laboratories | Optis Coronary Imaging System | $175 | 4 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $99 | 4 payments
|
| Teleflex | Interventional Products | $36 | 2 payments
|
| Chiesi USA | Kengreal 50mg/10ml L | $25 | 1 payment
|
| Medtronic Vascular | Micra | $16 | 1 payment
|
| Abiomed | Impella | $16 | 1 payment
|
| Astellas Pharma US | Lexiscan | $14 | 1 payment
|
2019: $413
| Medtronic USA | Kyphon Balloon Kyphoplasty | $167 | 2 payments
|
| Medtronic Vascular | Micra | $123 | 5 payments
|
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $47 | 2 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $44 | 2 payments
|
| Teleflex | Catheter - Turnpike | $32 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1750440491
- Licence
- CA A95410California A95410: Current · expires 2027-10-31
- Trained
- Albany Medical College of Union University, 2004 · 22 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 12462 Putnam St, Suite 203, Whittier, CA, 90602
- NPI first listed
- 2006-12-08
- NPI last updated
- 2011-06-11
This is when the NPI record was last certified, not a medical board exam.